ECONOMY ANALYSIS
Sensex closes flat; Sun Pharma up 4%, Tata Motors down 2%
Bajaj Hindusthan: Outcome of board meeting
SBI Life to appeal against IRDA's Rs 275cr refund order
Review: Property prices trends across metros
Saurashtra Paper & Board Mills fixes book closure for AGM
Zee Entertainment Enterprises: Outcome of board meeting (Changes in Directorship).
MARKET ANALYSIS
MUMBAI: The BSE benchmark index Sensex today recovered by 29 points in a volatile trade on selective buying in pharma, FMCG and banking stocks even as global markets remained weak on concerns over China's growth.
The 30-share index, which had lost 108.41 points in the previous session, rose by 29.80 points, or 0.14 per cent, to close at 21,856.22 points. It touched a day's low of 21,768.14 and a high of 21,965.95 points in a volatile trade.
Sun PharmaBSE 4.08 %, which received US FDA approval for generic Temodar drug, was the biggest gainer among 30 Sensex scrips. It rose by 4.08 per cent.
FMCG major ITCBSE 2.08 % rose by 2.08 per cent, Hero MotoCorpBSE 2.24 % by 2.16 per cent, TCSBSE 1.33 % by 1.33 per cent and WiproBSE 1.15 % by 1.15 per cent.
Stocks of pharma and software industries were back in demand and recovered as rupee declined, brokers said.
Sensex closes flat; Sun Pharma up 4%, Tata Motors down 2%
Bajaj Hindusthan: Outcome of board meeting
SBI Life to appeal against IRDA's Rs 275cr refund order
Review: Property prices trends across metros
Saurashtra Paper & Board Mills fixes book closure for AGM
Zee Entertainment Enterprises: Outcome of board meeting (Changes in Directorship).
MARKET ANALYSIS
MUMBAI: The BSE benchmark index Sensex today recovered by 29 points in a volatile trade on selective buying in pharma, FMCG and banking stocks even as global markets remained weak on concerns over China's growth.
The 30-share index, which had lost 108.41 points in the previous session, rose by 29.80 points, or 0.14 per cent, to close at 21,856.22 points. It touched a day's low of 21,768.14 and a high of 21,965.95 points in a volatile trade.
Sun PharmaBSE 4.08 %, which received US FDA approval for generic Temodar drug, was the biggest gainer among 30 Sensex scrips. It rose by 4.08 per cent.
FMCG major ITCBSE 2.08 % rose by 2.08 per cent, Hero MotoCorpBSE 2.24 % by 2.16 per cent, TCSBSE 1.33 % by 1.33 per cent and WiproBSE 1.15 % by 1.15 per cent.
Stocks of pharma and software industries were back in demand and recovered as rupee declined, brokers said.
0 comments:
Post a Comment